feed,title,long_url,short_url
Benzinga,"AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage Lung Cancer, But Hits Primary Goal In Phase 3 Bladder Cancer Study",https://benzinga.com/general/biotech/24/06/39480495/astrazenecas-blockbuster-cancer-drug-imfinzi-flunks-as-follow-up-in-type-of-early-stage-lung-canc,https://da.gd/eCDKS3
